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Received June 13, 2013; accepted August 26, 2013AbstractLudwig's angina is a life-threatening cellulitis that involves the submandibular and sublingual spaces. It often occurs after an infection of the
roots of the teeth. However, modern dental care and use of antibiotics for oral infections have made Ludwig's angina rare. We present here a
cancer patient exhibiting the sequential features of bisphosphonate related osteonecrosis of the jaw on bone scan complicating with Ludwig's
angina. This report highlights the need for medical practitioners to be alert to these rare combinations in the compromised patient after
bisphosphonate therapy. To the best of our knowledge, no case of Ludwig's angina secondary to osteonecrosis of the jaw has been reported.
Copyright © 2014 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Ludwig's angina is an infection of the submandibular and
sublingual spaces. It can potentially lead to a fatal airway
obstruction. It often occurs after an infection of themandible.We
present here a cancer patient exhibiting the sequential features of
bisphosphonate-related osteonecrosis of the jaw (BRONJ) on
bone scan and complicating with Ludwig's angina. This report
highlights that practitioners should be alert to these rare combi-
nations in the compromised patient after bisphosphonate therapy.
2. Case Report
An 83-year-old man, who had been diagnosed 2 years
earlier with prostate cancer, presented with submandibularConflicts of interest: The authors declare that there are no conflicts of interest
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1726-4901/Copyright © 2014 Elsevier Taiwan LLC and the Chinese Medical Assswelling and inability to swallow saliva for 1 week. With
preliminary assessment as Ludwig's angina at a local hospital,
and patient had undergone antibiotic prophylaxis and to ab-
scess drainage prior to the referral. He was nonfebrile and not
in respiratory distress. Computed tomography of his neck
showed a significant inflammation with abscess and fistula
formation in the left submandibular space. Presence of peri-
osteal reaction, osteolytic and osteoblastic change, bone
sequestration, and destruction of the mandible were noted
(Fig. 1).
Tc-99m methylene diphosphonate bone scan (Fig. 2)
exhibited intense bone lesion in the lower jaw (black arrow)
and evidence of distant bone metastasis (open arrows). He was
admitted to the dental ward for airway observation and further
treatment in September 2010. The aerobic and anaerobic
cultures of his blood yielded negative results. Empirical use of
1200 mg augmentin and 500 mg metronidazole intravenously
q. 8 hours was given. Subsequently the patient received
sequestectomy of the mandible and oral mucosa flap recon-
struction. During the operation, an open wound over the leftociation. All rights reserved.
Fig. 1. Contrast-enhanced computed tomography (A, sagittal; B, coronal-reformatted) images show extensive subcutaneous swelling, abscess (asterisk) in the
submandibular space and a fistula (arrow) noted. The airway is patent. (C) Bone window image revealing periosteal reaction, osteolytic and osteoblastic changes,
and intramedullary sequestra within the mandibular body (open arrow). The computed tomography findings are consistent with osteonecrosis of the jaw.
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were found. Histologically, inflammatory cell infiltration, and
granulation of soft-tissue were observed. Bone sequestration,
necrosis, and ingrowth of squamous epithelium in the
mandible were also noted (Fig. 3). A diagnosis of Stage 2Fig. 2. Tc-99m methylene diphosphonate bone scan exhibited intense bone lesion
arrows).BRONJ, distinguished by bone exposure with soft-tissue and
mandible infection, was confirmed. His pus culture yielded no
bacterial growth due to the recent antibiotics exposure. The
patient was then switched to 1 g augmentin tablet twice daily.
Subsequent follow-up at 2 weeks and 3 months at thein the lower jaw (black arrow) and evidence of distant bone metastasis (open
Fig. 3. (A) Low power (100) hematoxylin and eosin histology demonstrating infiltration of inflammatory cells (arrow) in the mandibular bone. (B) Osteonecrosis.
Dead bone with empty lacunae (arrows) noted. The histology is consistent with necrosis of the bone.
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swelling. Thereafter, our service had no further contact with
the patient.
Regarding his past medical history (Fig. 4), the patient had
prostate cancer (Gleason score 4 þ 3) with urinary bladder
invasion and distant skeletal spreading that was treated with
palliative prostatectomy in October 2008, and intravenous
zoledronic acid monthly thereafter. With partial response of
metastatic disease after 1 year of the therapy, the patient
sought dental care for a nonhealing tooth socket in the left
lower jaw. He underwent several courses of antibiotics therapy
with no significant improvement. In June 2010, an area of
infected and exposed necrotic bone in the left mandible was
noted, consistent with Stage 2 BRONJ according to the
American Association of Oral and Maxillofacial Surgeons
criteria. Zoledronic acid was then discontinued and hormone
therapy was provided.
3. Discussion
Bisphosphonates are inhibitors of osteoclastic bone
resorption, indicated for the treatment of an array of boneFig. 4. Sequential changes of the osteonecrosis of the jaw on Tc-99m methylene d
acid to treat distant bone metastases (open arrows). After 1 year of therapy with part
healing tooth socket in the left mandible (black arrow). In June 2010, a necrotic
bisphosphonate-related osteonecrosis of the jaw (black arrow). Hormone therapy w
2010 (Fig. 2).disorders. Suppressed bone turnover by bisphosphonates adds
to microdamage accumulation and danger of infections.
BRONJ, which was first described in 2003,1 is a rare but
serious side effect of treatment with bisphosphonates. About
95% of cases occurred among cancer patients receiving high-
dose intravenous bisphosphonates.2
The working definitions of BRONJ have been proposed as
the development of necrotic bone in the oral cavity of a patient
who is receiving bisphosphonate treatment, despite adequate
treatment for 8 weeks, without malignancy and no prior
radiotherapy to the head and neck.3 Patients with BRONJ are
categorized into three stages according to the clinical signs
and symptoms. Briefly, patients with Stage 1 disease have
exposed bone but are asymptomatic. Stage 2 disease is char-
acterized by exposed bone with regional soft-tissue infection.
Patients exhibiting exposed bone associated with soft-tissue
infection, and accompanied by pathologic fracture, oral-
cutaneous fistula, or osteolysis extending to the inferior
border are considered Stage 3. The underlying etiology and the
predilection of BRONJ remain unclear. Estilo et al4 reported
that Actinomyces colonization was found in all 310 biopsy
cases. Other authors have described that biofilms could beiphosphonate scanning. In October 2008, the patient took monthly zoledronic
ial response of metastatic disease, the patient sought dental treatment for a non-
bone in the left mandible was noted clinically, consistent with the criteria of
as given instead of zoledronic acid. Ludwig's angina developed in September
79R.-H. Yang et al. / Journal of the Chinese Medical Association 78 (2015) 76e79identified on the bone/tooth and mucosal surfaces around
BRONJ that are composed of Actinomyces and other organ-
isms.4,5 However, it is unclear if bisphosphonates causes direct
toxicity to the bone and/or soft tissues, which is infected
secondarily,6,7 or if infection is the immediate cause exacer-
bated by the use of bisphosphonates. Nevertheless, necrotic
bone may be the infectious source in the oral cavity, especially
in immunocompromised patients who are under chemo-
therapy. Furthermore, the lesion may progress to cause a
serious complication, as was the case in our patient.
BRONJ appears to be time-dependent with higher risk after
long-term use of bisphosphonate.8 Our patient had been
treated with zoledronic acid for >1 year. Although he was
followed-up by appropriate dental care, the presence of
osteonecrosis was not noticeable initially. However, a small
focus had been seen in the lower jaw about 19 months before
the patient's surgeon was aware of his problems and took
intervention (Fig. 4). It is not clear whether the radiotracer
deposits in BRONJ bone or the surrounding reactive bone.4
Nevertheless, increased uptake on bone scintigraphy is noted
in a majority of BRONJ cases, varying from 60% to >90%.4,9
Dore et al10 described the high sensitivity of bone scanning in
identifying BRONJ in the early stage, especially with single-
photon emission computed tomography/computed tomogra-
phy. Generally speaking, bone scintigraphy appears to be a
sensitive but not specific modality in this setting and is
considered valuable in delineating early BRONJ in most cases.
Ludwig's angina, characterized as a rapidly progressive
gangrenous cellulitis of the mouth floor, is an ear, nose, and
throat emergency. It can lead to lethal consequences due to
airway obstruction. Most cases of Ludwig's angina are odon-
togenic in etiology, primarily resulting from infections of the
second and third molars, where BRONJ happens to occur most
readily. Once infection develops, it spreads contiguously to the
sublingual space and may spread to the deep neck space.Although no similar case has been reported, the authors sug-
gest that BRONJ may be a risk factor of submandibular and
sublingual infection, and when a cancer patient is treated with
zoledronic acid, Tc-99m methylene diphosphonate bone
scintigraphy is considered as a reasonably effective diagnostic
tool to identify BRONJ in the early stage.
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